Clincosm LogoSign in Get a demo

leukemia, myeloid, acute

Showing 26 - 50 of 163
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Measurable Residual Disease in Acute Myeloid Leukemia as

Terminated
  • Leukemia, Myeloid, Acute
  • Measurable residual disease measured by flow cytometry
  • Heidelberg, BW, Germany
    University Hospital Heidelberg
Sep 12, 2022

Leukemia, Myeloid, Acute Trial in Portugal, Spain (Pevonedistat, Azacitidine)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Coimbra, Portugal
  • +63 more
Sep 9, 2022

Azacitidine in International Prognostic Scoring System

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
    • Hefei, Anhui, China
    • +16 more
    Sep 6, 2022

    Leukemia, Myeloid, Acute Trial in Worldwide (AG-120, Azacitidine, AG-221)

    Active, not recruiting
    • Leukemia, Myeloid, Acute
    • Duarte, California
    • +72 more
    Aug 18, 2022

    Leukemia, Myeloid, Acute Trial in Baltimore (Flotetuzumab)

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Aug 16, 2022

    Leukemia, Myeloid, Acute Trial in Worldwide (JNJ-75276617, Venetoclax (VEN), Azacitidine (AZA))

    Recruiting
    • Leukemia, Myeloid, Acute
    • Birmingham, Alabama
    • +30 more
    Aug 11, 2022

    A Long-term Follow-up Study of Patients Who Received VOR33

    Recruiting
    • Leukemia, Myeloid, Acute
    • VOR33
    • La Jolla, California
    • +7 more
    Aug 9, 2022

    Leukemia, Myeloid, Acute Trial in Japan (Cusatuzumab, Azacitidine)

    Completed
    • Leukemia, Myeloid, Acute
    • Fukushima, Japan
    • +4 more
    Aug 8, 2022

    Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-90009)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Myelodysplastic Syndromes
    • New Haven, Connecticut
    • +23 more
    Aug 1, 2022

    Leukemia, Myeloid, Acute, Relapsed Adult AML, Refractory Leukemia Trial in Xiamen (venetoclax combining chidamide and

    Recruiting
    • Leukemia, Myeloid, Acute
    • +2 more
    • venetoclax combining chidamide and azacitidine (VCA)
    • Xiamen, Fujian, China
      Bing Xu
    Aug 1, 2022

    Leukemia, Myeloid, Acute Trial in Guanzhou (Azacitidine, Venetoclax)

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • Guanzhou, Guandong, China
      Nanfang Hospital of Southern Medical University
    Jul 22, 2022

    Leukemia, Myeloid, Acute, MDS Trial in Wurzburg (TCM allogeneic humane central memory T cells, cryopreserved)

    Completed
    • Leukemia, Myeloid, Acute
    • Myelodysplastic Syndromes
    • TCM allogeneic humane central memory T cells, cryopreserved
    • Wurzburg, Germany
      University Hospital Wuerzburg - Department of Medicine II
    Jul 12, 2022

    Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Acute, Lymphoma Trial in Aurora (Diet Intervention)

    Recruiting
    • Leukemia, Lymphocytic, Acute
    • +3 more
    • Diet Intervention
    • Aurora, Colorado
    • +1 more
    Jun 29, 2022

    Leukemia, Myeloid, Acute, MDS Trial in Japan, Korea, Republic of, Taiwan (Pevonedistat 25 mg/m^2, Pevonedistat 44 mg/m^2,

    Completed
    • Leukemia, Myeloid, Acute
    • Myelodysplastic Syndromes
    • Pevonedistat 25 mg/m^2
    • +4 more
    • Maebashi City, Japan
    • +8 more
    Jun 23, 2022

    Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, L1, Leukemia, Lymphoblastic, Acute, L2 Trial in Melbourne (Venetoclax,

    Recruiting
    • Leukemia, Myeloid, Acute
    • +5 more
    • Melbourne, Victoria, Australia
      Melbourne Health
    Jun 19, 2022

    Leukemia, Myeloid, Acute Trial (GSK3745417)

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • (no location specified)
    Jun 15, 2022

    Analyze Occurrence of Transformation From Myelodysplastic

    Completed
    • Myelodysplastic Syndromes
    • Leukemia, Myeloid, Acute
      • Kobe, Hyogo, Japan
        Shinko Hospital
      Jun 13, 2022

      Leukemia, Myeloid, Acute, MDS Trial in Worldwide (Azacitidine, Durvalumab)

      Active, not recruiting
      Has Results
      • Leukemia, Myeloid, Acute
      • Myelodysplastic Syndromes
      • New Haven, Connecticut
      • +94 more
      Jun 9, 2022

      Leukemia, Myeloid, Acute Trial in United States (CPX-351, Quizartinib)

      Terminated
      Has Results
      • Leukemia, Myeloid, Acute
      • Denver, Colorado
      • +4 more
      May 10, 2022

      Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Japan, United States (DSP-5336)

      Recruiting
      • Leukemia, Myeloid, Acute
      • Leukemia, Lymphocytic, Acute
      • Houston, Texas
      • +5 more
      May 31, 2022

      Leukemia, Myeloid, Acute Trial in Seoul (Idarubicin)

      Recruiting
      • Leukemia, Myeloid, Acute
      • Seoul, Korea, Republic of
        Division of Hematology-Oncology, Konkuk University Medical Cente
      Apr 8, 2022

      Leukemia, Myeloid, Acute Trial in Poland (Liposomal Annamycin)

      Active, not recruiting
      • Leukemia, Myeloid, Acute
      • Liposomal Annamycin
      • Poznań, Poland
      • +4 more
      Apr 4, 2022

      Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))

      Recruiting
      • Leukemia, Myeloid, Acute
      • +2 more
      • H3B-8800 (RVT-2001)
      • Stanford, California
      • +26 more
      Mar 23, 2022

      Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-95251, Azacitidine)

      Recruiting
      • Leukemia, Myeloid, Acute
      • Myelodysplastic Syndromes
      • Marina Del Rey, California
      • +35 more
      Mar 11, 2022

      Leukemia, Myeloid, Acute Trial in United States (Liposomal Annamycin)

      Completed
      Has Results
      • Leukemia, Myeloid, Acute
      • Liposomal Annamycin
      • La Jolla, California
      • +3 more
      Feb 28, 2022